Talus Bioscience Raises $11.2M Seed+ Round Led by Two Bear Capital to Expand MARMOT AI Platform for Transcription Factor Therapeutics
Talus Bioscience raised $11.2M in Seed+ funding led by Two Bear Capital to expand its MARMOT AI platform that discovers and optimizes transcription factor modulators, accelerating programs targeting Brachyury-driven cancers and a prostate cancer–linked transcription factor.
More: Fierce Biotech, GeekWire
-
Fierce Biotech / Gabrielle Masson: Talus Bio raises $11.2M seed+ to advance MARMOT platform and target hard-to-reach transcription factors in cancer
-
GeekWire / Gillian Dohrn: Talus Bioscience Raises $11.2M to Develop Drugs Targeting Undruggable Gene-Regulating Proteins
No comments yet.